Yves Collette

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Venues

Cancers

Molecular cancer therapeutics

Cancer research

Biology of the cell

INSERM Délégation régionale Provence Alpes Cote d'Azur et Corse

Université Libre de Bruxelles (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

INSERM Délégation régionale Provence Alpes Cote d'Azur et Corse

France

DR2

Education History

Université Libre de Bruxelles

Belgium

PHD

Publications

Sylvain Garciaz, Marie-Anne Hospital, Yves Collette, Norbert Vey
Venetoclax Resistance in Acute Myeloid Leukemia. Cancers 16 (6) (2024)
Manuela Bratti, Elisa Stubbs, Sergii Kolodych, Herve Souchet, Lois Kelly, Johanna Merlin, Michelle Marchal, Rémy Castellano, Emmanuelle Josselin, Hélène Pasquer, Lina Benajiba, Alexandre Puissant, Oleksandr Koniev, Yves Collette, Coralie Belanger, Olivier Hermine, Renato C Monteiro, Pierre Launay
INA03, a potent transferrin-competitive antibody-drug conjugate against CD71, for a safer acute leukemia treatment. Molecular cancer therapeutics (2024)
Manuela Bratti, Elisa Stubbs, Sergii Kolodych, Herve Souchet, Lois Kelly, Johanna Merlin, Michelle Marchal, Rémy Castellano, Emmanuelle Josselin, Hélène Pasquer, Lina Benajiba, Alexandre Puissant, Oleksandr Koniev, Yves Collette, Coralie Belanger, Olivier Hermine, Renato C Monteiro, Pierre Launay
INA03: A Potent Transferrin-Competitive Antibody-Drug Conjugate against CD71 for Safer Acute Leukemia Treatment. Molecular cancer therapeutics 23 (8) (2024)
Manuela Bratti, Elisa Stubbs, Sergii Kolodych, Herve Souchet, Lois Kelly, Johanna Merlin, Michelle Marchal, Rémy Castellano, Emmanuelle Josselin, Hélène Pasquer, Lina Benajiba, Alexandre Puissant, Oleksandr Koniev, Yves Collette, Coralie Belanger, Olivier Hermine, Renato C Monteiro, Pierre Launay
INA03: A Potent Transferrin-Competitive Antibody-Drug Conjugate against CD71 for Safer Acute Leukemia Treatment. Molecular cancer therapeutics 23 (8) (2024)
Sylvain Garciaz, Marie-Anne Hospital, Yves Collette, Norbert Vey
Venetoclax Resistance in Acute Myeloid Leukemia. Cancers 16 (6) (2024)
Marie Sabatier, Rudy Birsen, Laura Lauture, Sarah Mouche, Paolo Angelino, Jonas Dehairs, Lea Goupille, Ismael Boussaid, Mael Heiblig, Emeline Boet, Ambrine Sahal, Estelle Saland, Juliana Carvalho Santos, Marc Armengol, Miranda Fernandez-Serrano, Thomas Farge, Guillaume Cognet, Federico Simonetta, Corentin Pignon, Antoine Graffeuil, Celine Mazzotti, Herve Avet-Loiseau, Oceane Delos, Justine Bertrand-Michel, Amelie Chedru, Vilma Dembitz, Paolo Gallipoli, Natasha S Anstee, Sun Loo, Andrew H Wei, Martin P Carroll, Armelle Goubard, Rémy Castellano, Yves Collette, François Vergez, Véronique De Mas, Sarah Bertoli, Suzanne Tavitian, Muriel Picard, Christian Recher, Nathalie H Bourgès-Abella, Fanny Granat, Olivier Kosmider, Pierre Sujobert, Benoit Colsch, Carine Joffre, Lucille Stuani, Johannes V Swinnen, Hervé Guillou, Gael Roué, Nawad Hakim, Anne S Dejean, Petros K Tsantoulis, Clément Larrue, Didier Bouscary, Jérome Tamburini, Jean-Emmanuel Sarry
C/EBPa confers dependence to fatty acid anabolic pathways and vulnerability to lipid oxidative stress-induced ferroptosis in FLT3-mutant leukemia. Cancer discovery (2023)
Thomas Farge, Jean Nakhle, Damien Lagarde, Guillaume Cognet, Nathaniel Polley, Rémy Castellano, Marie-Laure Nicolau, Claudie Bosc, Marie Sabatier, Ambrine Sahal, Estelle Saland, Yannick Jeanson, Nathan Guiraud, Emeline Boet, Camille Bergoglio, Mathilde Gotanègre, Pierre-Luc Mouchel, Lucille Stuani, Clément Larrue, Marie Sallese, Véronique De Mas, Cedric Moro, Cédric Dray, Yves Collette, Isabelle Raymond Letron, Isabelle Ader, Christian Recher, Jean-Emmanuel Sarry, Florence Cabon, François Vergez, Audrey Carrière
CD36 drives metastasis and relapse in acute myeloid leukemia. Cancer research (2023)
Raphael Leblanc, Rania Ghossoub, Armelle Goubard, Rémy Castellano, Joanna Fares, Luc Camoin, Stephane Audebert, Marielle Balzano, Berna Bou-Tayeh, Cyril Fauriat, Norbert Vey, Sylvain Garciaz, Jean-Paul Borg, Yves Collette, Michel A Aurrand-Lions, Guido David, Pascale Zimmermann
Downregulation of stromal syntenin sustains AML development. EMBO molecular medicine (2023)
Magali Saez-Ayala, Laurent Hoffer, Sébastien Abel, Khaoula Ben Yaala, Benoit Sicard, Guillaume P Andrieu, Mehdi Latiri, Emma K Davison, Marco A Ciufolini, Paul Brémond, Etienne Rebuffet, Philippe Roche, Carine Derviaux, Edwige Voisset, Camille Montersino, Remy Castellano, Yves Collette, Vahid Asnafi, Stéphane Betzi, Patrice Dubreuil, Sébastien Combes, Xavier Morelli
From a drug repositioning to a structure-based drug design approach to tackle acute lymphoblastic leukemia. Nature communications 14 (1) (2023)
Justine Decroocq, Rudy Birsen, Camille Montersino, Prasad Chaskar, Jordi Mano, Laury Poulain, Chloe Friedrich, Anne-Sophie Alary, Hélène Guermouche, Ambrine Sahal, Guillemette Fouquet, Mathilde Gotanègre, Federico Simonetta, Sarah Mouche, Pierre Gestraud, Auriane Lescure, Elaine Del Nery, Claudie Bosc, Adrien Grenier, Fetta Mazed, Johanna Mondesir, Nicolas Chapuis, Liza Ho, Aicha Boughalem, Marc Lelorc'h, Camille Gobeaux, Michaela Fontenay, Christian Recher, Norbert Vey, Arnaud Guillé, Daniel Birnbaum, Olivier Hermine, Isabelle Radford-Weiss, Petros Tsantoulis, Yves Collette, Rémy Castellano, Jean-Emmanuel Sarry, Éric Pasmant, Didier Bouscary, Olivier Kosmider, Jérome Tamburini
RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia. Leukemia 36 (5) (2022)
Florent Colin, Kristine Schauer, Ali Hamiche, Pierre Martineau, Jean-Paul Borg, Jan Bednar, Giulia Bertolin, Luc Camoin, Yves Collette, Stephan Dimitrov, Isabelle Fournier, Vincent Hyenne, Marco Antonio Mendoza-Parra, Xavier Morelli, Philippe Rondé, Izabela Sumara, Marc Tramier, Patrick Schultz, Jacky G Goetz
The NANOTUMOR consortium - Towards the Tumor Cell Atlas. Biology of the cell 113 (6) (2021)
Aude De Gassart, Kieu-Suong Le, Patrick Brune, Sophie Agaugué, Jennifer Sims, Armelle Goubard, Rémy Castellano, Noémie Joalland, Emmanuel Scotet, Yves Collette, Emmanuel Valentin, Clement Ghigo, Christine Pasero, Magali Colazet, Jaime Guillén, Carla E Cano, Aurélien Marabelle, Johann S de Bono, René Hoet, Alemseged Truneh, Daniel Olive, Paul A Frohna
Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell-mediated antitumor immune response. Science translational medicine 13 (616) (2021)
Andria Rakotomalala, Quentin Bailleul, Clara Savary, Mélanie Arcicasa, Maud Hamadou, Paul Huchedé, Audrey Hochart, Audrey Restouin, Remy Castellano, Yves Collette, Emma Dieny, Audrey Vincent, Pierre-Olivier Angrand, Xuefen Le Bourhis, Pierre Leblond, Alessandro Furlan, Marie Castets, Eddy Pasquier, Samuel Meignan
H3.3K27M Mutation Controls Cell Growth and Resistance to Therapies in Pediatric Glioma Cell Lines. Cancers 13 (21) (2021)
Jeremy Ariey-Bonnet, Kendall Carrasco, Marion Le Grand, Laurent Hoffer, Stéphane Betzi, Mikael Feracci, Philipp Tsvetkov, François Devred, Yves Collette, Xavier Morelli, Pedro J Ballester, Eddy Pasquier
In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor. Molecular oncology 14 (12) (2020)

Yves Collette.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yves Collette